StockData
Perspective Therapeutics, Inc. logo

Perspective Therapeutics, Inc. (CATX) stock

CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)

Close on Nov 20, 2026Market cap $86.05MP/E –Yield –

Perspective Therapeutics cash

Cash and short-term investments held at the end of each period.

Perspective Therapeutics's cash was $236.90M at Jun 30, 2026. For fiscal 2025 it was $144.70M, down 36.2% from the year before. Over ten years it grew 23.4% a year on average. The highest annual figure on record is $226.90M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$144.70M-36.2%
FY2024Dec 31, 2024$226.90M+306.0%
FY2022Jun 30, 2022$55.89M-12.4%
FY2021Jun 30, 2021$63.83M+2568.4%
FY2020Jun 30, 2020$2.39M-55.1%
FY2019Jun 30, 2019$5.33M+55.5%
FY2018Jun 30, 2018$3.43M-62.6%
FY2017Jun 30, 2017$9.15M-27.2%
FY2016Jun 30, 2016$12.57M-13.9%
FY2015Jun 30, 2015$14.59M-17.5%
FY2014Jun 30, 2014$17.68M+509.8%
FY2013Jun 30, 2013$2.90M+8.5%
FY2012Jun 30, 2012$2.67M+26.5%
FY2011Jun 30, 2011$2.11M+25.8%
FY2010Jun 30, 2010$1.68M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$236.90M+23.6%
Q1 FY2026CQ1 2026Mar 31, 2026$270.90M+28.0%
Q4 FY2025CQ4 2025Dec 31, 2025$144.70M-36.2%
Q3 FY2025CQ3 2025Sep 30, 2025$174.10M-35.0%
Q2 FY2025CQ2 2025Jun 30, 2025$191.60M-34.6%
Q1 FY2025CQ1 2025Mar 31, 2025$211.70M+17.2%
Q4 FY2024CQ4 2024Dec 31, 2024$226.90M+306.0%
Q3 FY2024CQ3 2024Sep 30, 2024$267.80M+354.6%
Q2 FY2024CQ2 2024Jun 30, 2024$292.90M+385.3%
Q1 FY2024CQ1 2024Mar 31, 2024$180.60M+192.8%
Q4 FY2022CQ2 2022Jun 30, 2022$55.89M-12.4%
Q3 FY2022CQ1 2022Mar 31, 2022$58.90M-9.2%
Q2 FY2022CQ4 2021Dec 31, 2021$60.35M+529.7%
Q1 FY2022CQ3 2021Sep 30, 2021$61.69M+3079.9%
Q4 FY2021CQ2 2021Jun 30, 2021$63.83M+2568.4%
Q3 FY2021CQ1 2021Mar 31, 2021$64.84M+2596.1%
Q2 FY2021CQ4 2020Dec 31, 2020$9.59M+201.4%
Q1 FY2021CQ3 2020Sep 30, 2020$1.94M-57.6%
Q4 FY2020CQ2 2020Jun 30, 2020$2.39M-55.1%
Q3 FY2020CQ1 2020Mar 31, 2020$2.41M-62.4%
Q2 FY2020CQ4 2019Dec 31, 2019$3.18M-59.6%
Q1 FY2020CQ3 2019Sep 30, 2019$4.58M-50.2%
Q4 FY2019CQ2 2019Jun 30, 2019$5.33M+55.5%
Q3 FY2019CQ1 2019Mar 31, 2019$6.39M+41.6%
Q2 FY2019CQ4 2018Dec 31, 2018$7.87M+38.6%
Q1 FY2019CQ3 2018Sep 30, 2018$9.19M+26.7%
Q4 FY2018CQ2 2018Jun 30, 2018$3.43M-62.6%
Q3 FY2018CQ1 2018Mar 31, 2018$4.52M-56.6%
Q2 FY2018CQ4 2017Dec 31, 2017$5.68M-52.5%
Q1 FY2018CQ3 2017Sep 30, 2017$7.26M-47.1%
Q4 FY2017CQ2 2017Jun 30, 2017$9.15M-27.2%
Q3 FY2017CQ1 2017Mar 31, 2017$10.41M-10.3%
Q2 FY2017CQ4 2016Dec 31, 2016$11.95M-5.2%
Q1 FY2017CQ3 2016Sep 30, 2016$13.71M+1.7%
Q4 FY2016CQ2 2016Jun 30, 2016$12.57M-13.9%
Q3 FY2016CQ1 2016Mar 31, 2016$11.60M+14.2%
Q2 FY2016CQ4 2015Dec 31, 2015$12.60M–
Q1 FY2016CQ3 2015Sep 30, 2015$13.48M–
Q4 FY2015CQ2 2015Jun 30, 2015$14.59M–
Q3 FY2015CQ1 2015Mar 31, 2015$10.16M–

More Perspective Therapeutics figures

See a number that looks wrong?